Abstract:Objective:To investigate the effects and clinical significance of NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activated by interleukin (IL)-17A in chronic rhinosinusitis with nasal polyps (CRSwNP).Methods:Patients underwent nasal endoscopic surgery in the Third Affiliated Hospital of Sun Yat-sen University from January 2020 to December 2021 were collected, including 28 CRSwNP (including 19 males and 9 females, aged 19 to 67 years), 22 chronic rhinosinusitis without nasal polyps (CRSsNP) and 22 controls. qRT-PCR was used to detect the expressions of IL-17A, NLRP3, IL-1β and IL-18 in the three groups, and their correlations were analyzed. The positions of IL-17A, NLRP3 and IL-18 in nasal polys were analyzed by immunofluorescence. Western Blotting and ELISA were employed to detect the expression of NLRP3, IL-1β and IL-18 in the human nasal epithelial cells after using IL-17A stimulation or IL-17A receptor inhibitor. Immunofluorescence was used to observe the NLRP3, IL-1β, and IL-18 protein expression after IL-17A stimulating human nasal epithelial cells, and after the use of IL-17A receptor inhibitor and NLRP3 inhibitor MCC950. The correlations between NLRP3, IL-1β, IL-18 and CT scores, nasal endoscopic scores, visual analogue scale (VAS) scores, and sino-nasal outcome test (SNOT) 22 scores of CRSwNP patients were analyzed. SPSS 20.0 software was used for statistical analysis.Results:The expressions of IL-17A, NLRP3, IL-1β and IL-18 in the tissues of CRSwNP patients were significantly higher than those in CRSsNP group( P=0.018, P<0.001, P=0.005, P=0.016) and the control group(all P<0.001). IL-17A was positively correlated with the expression of NLRP3, IL-1β, and IL-18( r ralue was 0.643,0.650,0.629,respectively, all P<0.05). IL-17A, NLRP3, and IL-18 were co-localized in the epithelial propria of polyp tissue. IL-17A stimulated the expressions of NLRP3, IL-1β, and IL-18 in human nasal epithelial cells. After the use of IL-17A receptor inhibitor, the expressions of NLRP3, IL-1β, and IL-18 were significantly down-regulated. After the use of NLRP3 inhibitor MCC950, IL-17A was significantly down-regulated to promote the expression of NLRP3, IL-1β, and IL-18. The expressions of NLRP3, IL-1β and IL-18 were positively correlated with CT, nasal endoscopy, VAS, and SNOT22 scores in patients with CRSwNP. Conclusions:IL-17A promotes the release of IL-1β and IL-18 by activating the NLRP3 inflammasome and aggravates the severity of the disease in CRSwNP.

Ifn-Lambda 1 Enhances Staphylococcus Aureus Clearance In Healthy Nasal Mucosa But Not In Nasal Polyps

IFN-λ1 enhances Staphylococcus aureus clearance in healthy nasal mucosa but not in nasal polyps.

Interleukin-17A expression in patients with chronic rhinosinusitis and its relationship with clinical features.

Roles Played by the PI3K/Akt/HIF-1α Pathway and IL-17A in the Chinese Subtype of Chronic Sinusitis with Nasal Polyps

The Inflammatory Microenvironment of Nasal Polyps in Patients with Chronic Rhinosinusitis and the Relationship of This Microenvironment with the Nasal Microbiome.

Increased IL-1α Expression in Chronic Rhinosinusitis with Nasal Polyps.

Reduced Proliferative Capacity and Defense against Staphylococcus aureus in Human Nasal Mucosal Epithelium Lacking ZNF365

Role of IFN‐γ, IL‐13, and IL‐17 on Mucociliary Differentiation of Nasal Epithelial Cells in Chronic Rhinosinusitis with Nasal Polyps

Increased IL-21 expression in chronic rhinosinusitis with nasalpolyps.

Effects and Clinical Significance of NLRP3 Inflammasome Activated by IL-17A in CRSwNP

The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps

The Antimicrobial Protein Short Palate, Lung, and Nasal Epithelium Clone 1 (SPLUNC1) is Differentially Modulated in Eosinophilic and Noneosinophilic Chronic Rhinosinusitis with Nasal Polyps.

Rhinitis, sinusitis, and ocular allergy IFN-l1 enhances Staphylococcus aureus clearance in healthy nasal mucosa but not in nasal polyps

The Intervention of CRAC Channels Alleviates Inflammatory Responses in Nasal Polyps.

Interleukin-17a Contributes to the Expression of Serum Amyloid A in Chronic Rhinosinusitis with Nasal Polyps

Reduced Expression of Antimicrobial Protein Secretory Leukoprotease Inhibitor and Clusterin in Chronic Rhinosinusitis with Nasal Polyps

Enhanced IL-37-IL-1R8 axis is negatively associated with inflammatory and clinical severity of chronic rhinosinusitis with nasal polyps

The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps.

Interleukin-17A Expression Correlated with the Prognosis of Chronic Rhinosinusitis with Nasal Polyps and the Anti-Interleukin-17A Effect in a Murine Nasal Polyps Model.

Expression and Regulation of Transcription Factor FoxA2 in Chronic Rhinosinusitis with and Without Nasal Polyps

IL-1β-induced epithelial cell and fibroblast transdifferentiation promotes neutrophil recruitment in chronic rhinosinusitis with nasal polyps